Home > Journals > Otorinolaringologia > Past Issues > Otorinolaringologia 2005 March;55(1) > Otorinolaringologia 2005 March;55(1):15-21





A Journal on Otorhinolaryngology, Head and Neck Surgery,
Plastic Reconstructive Surgery, Otoneurosurgery

Indexed/Abstracted in: EMBASE, Scopus




Otorinolaringologia 2005 March;55(1):15-21

language: English

Sublingual immunotherapy for allergic rhinitis

Passalacqua G., Compalati E., Guerra L., Canonica G. W.

Allergy and Respiratory Diseases Department of Internal Medicine University of Genoa, Genoa, Italy


Sublingual immunotherapy (SLIT) has been recently approved for clinical use in the treatment of respiratory allergy. This paper reviews the data available in literature concerning the efficacy and safety of SLIT in rhinitis. SLIT appears effective and safe both in adults and children, sharing with subcutaneous route the long lasting efficacy, the preventative effect on asthma onset and the mechanisms of action. Sublingual administration represents a valid alternative to subcutaneous immunotherapy and seems to be especially promising in the pediatric fields of application. Future research will investigate and settle the optimal maintenance dose, the analysis of the cost/effectiveness ratio, the identification of subsets of patients able to most benefit from either of the 2 routes of administration.

top of page

Publication History

Cite this article as

Corresponding author e-mail